LWCFA
AGN

Loring Wolcott & Coolidge Fiduciary Advisors’s Allergan Inc AGN Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-824
Closed -$139K – 640
2014
Q2 		$139K Hold
824
– – ﹤0.01% 314
2014
Q1 		$102K Buy
824
+25
+3% +$3.04K ﹤0.01% 343
2013
Q4 		$89K Buy
+799
New +$76.3K ﹤0.01% 343

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's AGN Position: Q3 2014 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 824 shares — an estimated $139K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in AGN in Q4 2013 and held it in 3 quarters. The position peaked at $139K in Q2 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 824 Allergan Inc shares in Q3 2014, an estimated $139K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Allergan Inc in Q4 2013 and held it in 3 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Allergan Inc position peaked at $139K in Q2 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2014, filed 7 Nov 2014.